Our analytical methods are designed to intelligently link microbiome components to clinical pathways, identifying crucial elements for predicting T2D risk.
DeepBiomics
Multi-Omics AI Analysis for Precision Healthcare
DeepBiomics integrates and analyzes multi-omics data through deep learning architectures purpose-built for biology. Our algorithms handle complex, high-dimensional datasets spanning genomics, transcriptomics, proteomics, and clinical phenotypes, delivering precision insights that inform better healthcare decisions. Whether you are running a clinical trial, evaluating a dietary intervention, or exploring disease biomarkers, DeepBiomics helps you extract meaningful patterns from noisy, high-dimensional data.
How Does DeepBiomics Work?
Innovative graph and network-based representation
Our graph and network-based models distill complex biological processes into clear, interpretable representations. By decomposing proteins, gene sequences and molecular pathways into structured components, DeepBiomics delivers rapid, accurate and personalized insights for biological research and precision healthcare.
Tailored Algorithms for a Holistic Understanding of Biological Systems
The DeepBiomics platform evaluates complex, high-dimensional biological data to deliver tailored healthcare insights. Our algorithms integrate a broad range of data modalities, including gene ontology, pathway databases, metagenomics, proteomics, epigenetics, 3D protein structures, cellular imaging, and large text corpora.
Capturing Biological Complexity with Precision
Our network and graph models capture the intricacies of biological systems and deliver precise, personalized insights. This reflects our mission to accelerate research and inform better healthcare decisions.
Explore our research areas
Type 2 Diabetes with AI and Microbiome Data
Cardiovascular Risk Prediction From Plasma Proteomics
Our models excel at identifying a constellation of key biomarkers, significantly enhancing the prediction of cardiovascular events.
Epigenetics and inflammatory bowel disease
Traditional treatment approaches often rely on a trial-and-error method due to the lack of reliable biomarkers to predict treatment outcomes.
